EMA committee approves two more manufacturing sites for Pfizer-BioNTech Covid-19 vaccine

Coronavirus chronicle

Reuters
22 June, 2021, 06:40 pm
Last modified: 22 June, 2021, 06:41 pm
Photo: Collected.

The European health regulator's committee for human medicines(CHMP) on Tuesday approved two additional manufacturing sites, in Germany and Switzerland, for the production of the Covid-19 vaccine developed by Pfizer Inc and BioNTech.

Related Topics

World+Biz

European Medicines Agency (EMA) / Pfizer Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.